Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-08 | Entrada Therapeutics, Inc. | KIM PETER S
(Director) |
P | Common Stock | A | 2600 | $13.57 - $13.57 | $35,289 |
2024-03-22 | Entrada Therapeutics, Inc. | KIM PETER S
(Director) |
P | Common Stock | A | 9048 | $13.36 - $13.76 | $122,881 |
2024-03-19 | Entrada Therapeutics, Inc. | KIM PETER S
(Director) |
P | Common Stock | A | 2732 | $12.66 - $13.24 | $34,993 |
2024-03-06 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
S | Common Stock | D | 4086 | $12.31 - $12.31 | $50,285 |
2024-03-04 | Entrada Therapeutics, Inc. | Doshi Dipal
(CEO) |
F | Common Stock | D | 7604 | $12.28 - $13.37 | $95,048 |
2024-03-01 | Entrada Therapeutics, Inc. | Doshi Dipal
(CEO) |
A | Common Stock | A | 104700 | $0.00 - $0.00 | $0 |
2024-03-04 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
F | Common Stock | D | 2215 | $12.28 - $13.37 | $27,686 |
2024-03-01 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
A | Common Stock | A | 30900 | $0.00 - $0.00 | $0 |
2024-03-04 | Entrada Therapeutics, Inc. | Dowden Nathan J
(President & COO) |
F | Common Stock | D | 2238 | $12.28 - $13.37 | $27,974 |
2024-03-01 | Entrada Therapeutics, Inc. | Dowden Nathan J
(President & COO) |
A | Common Stock | A | 93100 | $0.00 - $0.00 | $0 |
2024-03-04 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(Chief Scientific Officer) |
F | Common Stock | D | 2266 | $12.28 - $13.37 | $28,323 |
2024-03-01 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(Chief Scientific Officer) |
A | Common Stock | A | 44100 | $0.00 - $0.00 | $0 |
2024-02-15 | Entrada Therapeutics, Inc. | Doshi Dipal
(CEO) |
S | Common Stock | D | 1000 | $15.00 - $15.00 | $15,000 |
2023-11-13 | Entrada Therapeutics, Inc. | Doshi Dipal
(President and CEO) |
S | Common Stock | D | 1000 | $16.23 - $16.23 | $16,230 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |